VA

VR Adviser Portfolio holdings

AUM $1.33B
This Quarter Return
+10.37%
1 Year Return
+6.92%
3 Year Return
+862.77%
5 Year Return
+1,580.48%
10 Year Return
–
AUM
$950M
AUM Growth
+$950M
Cap. Flow
+$335M
Cap. Flow %
35.21%
Top 10 Hldgs %
62.17%
Holding
40
New
10
Increased
7
Reduced
3
Closed
3

Top Buys

1
APGE icon
Apogee Therapeutics
APGE
$181M
2
RYZB
RayzeBio, Inc. Common Stock
RYZB
$89.2M
3
TSHA icon
Taysha Gene Therapies
TSHA
$45.6M
4
HLVX icon
HilleVax
HLVX
$27.4M
5
TVTX icon
Travere Therapeutics
TVTX
$23.5M

Top Sells

1
GHRS icon
GH Research
GHRS
$7.77M
2
THRX
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$7.18M
3
AMAM
Ambrx Biopharma, Inc. Common Stock
AMAM
$4.77M
4
BDTX icon
Black Diamond Therapeutics
BDTX
$1.79M
5
AVTX icon
Avalo Therapeutics
AVTX
$444K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
PRAX icon
26
Praxis Precision Medicines
PRAX
$980M
$9.07M 0.95%
5,304,410
– –
SLRN
27
DELISTED
ACELYRIN
SLRN
$8.79M 0.93%
+864,332
New +$8.79M
TRVI icon
28
Trevi Therapeutics
TRVI
$871M
$7.46M 0.79%
3,422,397
– –
ACRS icon
29
Aclaris Therapeutics
ACRS
$223M
$7.13M 0.75%
1,040,754
– –
MIST icon
30
Milestone Pharmaceuticals
MIST
$151M
$6.85M 0.72%
2,208,812
– –
PLRX icon
31
Pliant Therapeutics
PLRX
$105M
$5.01M 0.53%
288,949
– –
SGMT icon
32
Sagimet Biosciences
SGMT
$239M
$4.53M 0.48%
+515,000
New +$4.53M
SYRE icon
33
Spyre Therapeutics
SYRE
$1.02B
$3.61M 0.38%
295,034
-6,048,187
-95% +$506K
LYRA icon
34
Lyra Therapeutics
LYRA
$11.8M
$3.61M 0.38%
924,170
– –
OLMA icon
35
Olema Pharmaceuticals
OLMA
$432M
$951K 0.1%
+77,042
New +$951K
RLYB icon
36
Rallybio
RLYB
$24.1M
$905K 0.1%
268,532
– –
AFMD
37
DELISTED
Affimed
AFMD
$683K 0.07%
1,428,571
– –
BDTX icon
38
Black Diamond Therapeutics
BDTX
$164M
– –
-353,629
Closed -$1.79M
AVTX icon
39
Avalo Therapeutics
AVTX
$139M
– –
-1,250,000
Closed -$444K
THRX
40
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
– –
-770,000
Closed -$7.18M
1
2